Stocks AFRI Financial statements
Financial statementsForafric Global PLC financial statements
Income statement, balance sheet and cash flow statement for the last 6 fiscal years, taken from the XBRL data Forafric Global PLC files with the SEC in its annual reports.
In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.
Income statement
| FY2020 | FY2022 | FY2022 | FY2023 | FY2024 | FY2025 | |
|---|---|---|---|---|---|---|
| Revenue | 197 | 262 | 284 | 302 | 274 | 176 |
| Cost of revenue | 156 | 219 | 255 | 273 | 247 | 158 |
| Gross profit | 40.4 | 42.4 | 29.2 | 28.5 | 27.3 | 18.4 |
| Selling, general and administrative | 30.5 | 39 | 26.9 | 27.3 | 35.1 | 22 |
| Operating expenses | 30.5 | 39 | 26.9 | 27.3 | 35.1 | 22 |
| Operating income | 9.89 | 3.39 | 2.28 | 1.24 | -7.76 | -3.56 |
| Interest expense | 6.85 | 10.4 | 12.5 | 14 | 12.8 | 14.3 |
| Interest income | 0 | 0.54 | 0.03 | 0.04 | 0.03 | 0.05 |
| Other non-operating income | -9.89 | -11.3 | -19.2 | -13.2 | -13.9 | -7.17 |
| Pre-tax income | 0 | -7.87 | -17 | -12 | -21.7 | -10.7 |
| Income tax | 0.14 | -0.09 | -1.84 | 0.59 | 1.65 | 1.38 |
| Income from continuing operations | -15.1 | -12.6 | -23.3 | -12.1 | ||
| Net income to minority interests | -0.03 | 0.2 | -0.04 | 0.17 | 0.97 | 1.1 |
| Net income | -0.11 | -7.98 | -19.1 | -12.7 | -24.3 | -14.9 |
| EBITDA | 13.5 | 7.31 | 6.99 | 5.74 | -3.42 | 1.24 |
| EPS, basic | -0.22 | -0.38 | -0.72 | -0.47 | ||
| EPS, diluted | -0.22 | -0.38 | -0.72 | -0.47 | ||
| Shares, basic (weighted) | 0.62 | 20.6 | 26.6 | 26.9 | 26.9 | 26.9 |
| Shares, diluted (weighted) | 0.62 | 20.6 | 26.6 | 26.9 | 26.9 | 26.9 |
Balance sheet
| FY2020 | FY2022 | FY2022 | FY2023 | FY2024 | FY2025 | |
|---|---|---|---|---|---|---|
| Cash and equivalents | 12.7 | 14.4 | 24.8 | 24 | 12.2 | 14.3 |
| Receivables | 32.3 | 30.9 | 34.7 | 18 | 14 | |
| Inventory | 37.6 | 27.2 | 28.4 | 15.2 | 14.1 | |
| Other current assets | 3.72 | 3.83 | 1.6 | 1.39 | 0.71 | |
| Total current assets | 118 | 144 | 121 | 77.4 | 68.2 | |
| Property, plant and equipment | 109 | 101 | 107 | 102 | 108 | |
| Lease right-of-use assets | 2.08 | 1.82 | 3.38 | 6.93 | 6.62 | |
| Goodwill | 48.1 | 51.6 | 41.7 | 44 | 42.9 | 46.6 |
| Intangible assets | 0.36 | 3.98 | 3.72 | 4.65 | 4.4 | 5.16 |
| Other non-current assets | 0.97 | 3.01 | 4.76 | 3.58 | 2.96 | |
| Total assets | 300 | 307 | 309 | 246 | 247 | |
| Accounts payable | 26.2 | 27.3 | 46.2 | 35.3 | 41.2 | |
| Accrued liabilities | 13.1 | 19 | 17.6 | 22.6 | 23.7 | |
| Short-term debt | 10.8 | 5.42 | 10.4 | 4.64 | 8.77 | |
| Total current liabilities | 203 | 238 | 254 | 207 | 208 | |
| Long-term debt | 14.1 | 9.83 | 11.8 | 13.1 | 17.6 | |
| Lease liabilities | 1.53 | 0.67 | 2.19 | 5.89 | 5.52 | |
| Other non-current liabilities | 15.3 | 2.68 | 3.09 | 2.61 | ||
| Total liabilities | 252 | 262 | 280 | 241 | 240 | |
| Total debt | 25 | 15.2 | 22.2 | 17.8 | 26.4 | |
| Paid-in capital | 120 | 144 | 143 | 144 | 152 | |
| Retained earnings | -83.6 | -103 | -115 | -140 | -155 | |
| Other comprehensive income | 3.69 | -2.98 | -5.01 | -5.67 | -6.19 | |
| Minority interests | 7.52 | 6.9 | 6.41 | 6.99 | 15.3 | |
| Total equity | 52 | 47.7 | 45 | 29.2 | 5.32 | 6.66 |
| Total liabilities and equity | 300 | 307 | 309 | 246 | 247 | |
| Shares outstanding | 26.9 | 26.9 | 26.9 | 26.9 |
Cash flow statement
| FY2020 | FY2022 | FY2022 | FY2023 | FY2024 | FY2025 | |
|---|---|---|---|---|---|---|
| Net income | -0.14 | -7.78 | -19.2 | -12.5 | -23.4 | -13.8 |
| Depreciation and amortization | 3.64 | 3.93 | 4.72 | 4.49 | 4.34 | 4.79 |
| Stock-based compensation | 0.13 | 0.17 | 0.52 | 0.4 | ||
| Deferred income tax | -1.88 | -2.59 | -3.88 | -1.29 | -0.58 | -0.31 |
| Change in receivables | 3.29 | -4.37 | -12.2 | -1.85 | 8.85 | 3.75 |
| Change in inventory | -11.7 | -9.83 | 6.13 | 1.66 | 10.1 | 0.6 |
| Change in payables | -4.05 | 2.33 | 14 | 8.95 | -10.9 | 3.51 |
| Cash from operations | -11.5 | -26 | -57.6 | 33.3 | 23.5 | 0.36 |
| Capital expenditures | -0.66 | -4.83 | -4.47 | -9.49 | -1.78 | -0.52 |
| Acquisitions | -8.64 | -0.04 | ||||
| Cash from investing | -0.7 | -14.5 | -4.03 | -9.84 | -2.06 | 7.28 |
| Debt issued | 108 | 164 | 193 | |||
| Debt repaid | -89.5 | -127 | -147 | |||
| Cash from financing | 18.8 | 42.8 | 75 | -21.2 | -33.2 | -6.12 |
| Exchange rate effect | -2.9 | -0.48 | -2.96 | -3.11 | -0.01 | 0.57 |
| Net change in cash | 3.69 | 1.71 | 10.4 | -0.81 | -11.8 | 2.08 |
| Free cash flow | -12.1 | -30.9 | -62 | 23.8 | 21.7 | -0.16 |
| Interest paid | 6.85 | 9.2 | 11.3 | 15.8 | 13.1 | 13.2 |
| Income taxes paid | 1.9 | 2.5 | 2.23 | 1.99 | 2.23 | 1.1 |
Key metrics
Profitability
| Metric | Value | How it is calculated |
|---|---|---|
| Gross margin | 10.4% | Gross profit / revenue. |
| Operating margin | -2.0% | Operating income / revenue. |
| EBITDA margin | 0.7% | EBITDA (operating income + depreciation and amortization) / revenue. |
| Pre-tax margin | -6.1% | Pre-tax income / revenue. |
| Net margin | -8.4% | Net income / revenue. |
| FCF margin | -0.1% | Free cash flow (cash from operations - capital expenditures) / revenue. |
| Operating cash flow margin | 0.2% | Cash from operations / revenue. |
| Return on assets (ROA) | -6.0% | Net income / average total assets. |
| SG&A / revenue | 12.4% | Selling, general and administrative expense / revenue. |
| Stock-based pay / revenue | 0.2% | Stock-based compensation (from the cash flow statement) / revenue. |
| Capex / revenue | 0.3% | Capital expenditures / revenue. |
| D&A / revenue | 2.7% | Depreciation and amortization / revenue. |
Growth
| Metric | Value | How it is calculated |
|---|---|---|
| Revenue growth, 1y | -35.6% | Revenue vs the same period a year earlier. Only from a positive base. |
| Revenue CAGR, 3y | -14.7% | Compound annual growth of revenue over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive. |
| Revenue CAGR, 5y | -2.1% | Compound annual growth of revenue over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive. |
| Gross profit growth, 1y | -32.7% | Gross profit vs the same period a year earlier. Only from a positive base. |
| Gross profit CAGR, 3y | -14.3% | Compound annual growth of gross profit over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive. |
| Gross profit CAGR, 5y | -14.6% | Compound annual growth of gross profit over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive. |
| EBITDA CAGR, 3y | -43.8% | Compound annual growth of ebitda over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive. |
| EBITDA CAGR, 5y | -38.0% | Compound annual growth of ebitda over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive. |
| Operating cash flow growth, 1y | -98.5% | Operating cash flow vs the same period a year earlier. Only from a positive base. |
| Free cash flow growth, 1y | -100.7% | Free cash flow vs the same period a year earlier. Only from a positive base. |
| Total assets growth, 1y | 0.3% | Total assets vs the same period a year earlier. Only from a positive base. |
| Total assets CAGR, 3y | -7.0% | Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive. |
| Share count change, 1y | 0.1% | Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution. |
| Share count change per year, 3y | 0.4% | Change in diluted weighted shares, per year over 3 years. Negative means buybacks shrank the share count; positive means dilution. |
| Share count change per year, 5y | 112.6% | Change in diluted weighted shares, per year over 5 years. Negative means buybacks shrank the share count; positive means dilution. |
Balance sheet health
| Metric | Value | How it is calculated |
|---|---|---|
| Current ratio | 0.33x | Current assets / current liabilities. |
| Quick ratio | 0.14x | (Cash + short-term investments + receivables) / current liabilities. |
| Cash ratio | 0.07x | (Cash + short-term investments) / current liabilities. |
| Debt / assets | 10.7% | Total debt / total assets. |
| Liabilities / assets | 97.3% | Total liabilities / total assets. |
| Net debt | $12.1M | Total debt - cash - short-term investments. Negative means more cash than debt. |
| Net debt / EBITDA | 9.76x | Net debt / EBITDA (twelve months), when EBITDA is positive. |
| Interest coverage | -0.25x | Operating income / interest expense. |
| Working capital | -$139.4M | Current assets - current liabilities. |
| Goodwill and intangibles / assets | 20.9% | (Goodwill + intangible assets) / total assets. |
Efficiency
| Metric | Value | How it is calculated |
|---|---|---|
| Asset turnover | 0.72x | Revenue / average total assets. |
| Fixed asset turnover | 1.69x | Revenue / average property, plant and equipment. |
| Inventory turnover | 10.8x | Cost of revenue / average inventory. |
| Days inventory | 34 days | 365 x average inventory / cost of revenue. |
| Receivables turnover | 11.1x | Revenue / average receivables. |
| Days sales outstanding | 33 days | 365 x average receivables / revenue. |
| Days payables | 88 days | 365 x average accounts payable / cost of revenue. |
| Cash conversion cycle | -21 days | Days inventory + days sales outstanding - days payables. |
| Capex / operating cash flow | 145.2% | Capital expenditures / cash from operations, when that is positive. |
Per share
| Metric | Value | How it is calculated |
|---|---|---|
| Revenue per share | $6.56 | Revenue / diluted weighted shares. |
| FCF per share | -$0.01 | Free cash flow / diluted weighted shares. |
| Operating cash flow per share | $0.01 | Cash from operations / diluted weighted shares. |
| Cash per share | $0.53 | (Cash + short-term investments) / shares outstanding. |
Valuation
| Metric | Value | How it is calculated |
|---|---|---|
| Market cap | $295.8M | Share price x shares outstanding. |
| Enterprise value | $307.9M | Market cap + total debt - cash - short-term investments. |
| P/S | 1.68x | Market cap / revenue. |
| P/OCF | 831x | Market cap / cash from operations, when positive. |
| EV/Sales | 1.74x | Enterprise value / revenue. |
| EV/EBITDA | 249x | Enterprise value / EBITDA, when both are positive. |
| FCF yield | -0.1% | Free cash flow / market cap. |
| Earnings yield | -5.0% | Net income / market cap (the inverse of P/E). |
What was Forafric Global PLC's revenue in fiscal 2025?
Forafric Global PLC reported revenue of $176.5M for fiscal 2025, 35.6% lower than the year before.
Was Forafric Global PLC profitable in fiscal 2025?
No. It reported a net loss of $14.9M.
How much free cash flow did Forafric Global PLC generate in fiscal 2025?
Cash from operations of $356.0K minus capital expenditures of $517.0K left free cash flow of -$161.0K.